The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial
Open accessPublished version of a preprint
Abstract
Background: As the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appropriately manage these patients, there have been a growing number of mobile apps designed to improve the self-management of diabetes. One such app, BlueStar, has been shown to significantly reduce hemoglobin A1c (HbA1c) levels in small studies and is the first app in the United States to receive Food and Drug Administration approval as a mobile prescription therapy. However, the impact of the app across real-world population among different clinical sites and health systems remains unclear. Objective: The primary objective of this study was to conduct a pragmatic randomized controlled trial of the BlueStar mobile app to determine if app usage leads to improved HbA1c levels among diverse participants in real-life clinical contexts. We hypothesized that this mobile app would improve self-management and HbA1c levels compared with controls. Methods: The study consisted of a multicenter pragmatic randomized controlled trial. Overall, 110 participants randomized to the immediate treatment group (ITG) received the intervention for 6 months, and 113 participants randomized to the wait-list control (WLC) group received usual care for the first 3 months and then received the intervention for 3 months. The primary outcome was glucose control measured by HbA1c levels at 3 months. Secondary outcomes assessed intervention impact on patient self-management, experience of care, and self-reported health utilization using validated scales, including the Problem Areas in Diabetes, the Summary of Diabetes Self-Care Activities, and the EuroQol-5D. Intervention usage data were collected directly from the app. Results: The results of an analysis of covariance controlling for baseline HbA1c levels did not show evidence of intervention impact on HbA1c levels at 3 months (mean difference [ITG−WLC] −0.42, 95% CI −1.05 to 0.21; P=.19). Similarly, there was no intervention effect on secondary outcomes measuring diabetes self-efficacy, quality of life, and health care utilization behaviors. An exploratory analysis of 57 ITG participants investigating the impact of app usage on HbA1c levels showed that each additional day of app use corresponded with a 0.016-point decrease in participants’ 3-month HbA1c levels (95% CI −0.03 to −0.003). App usage varied significantly by site, as participants from 1 site logged in to the app a median of 36 days over 14 weeks (interquartile range [IQR] 10.5-124); those at another site used the app significantly less (median 9; IQR 6-51). Conclusions: The results showed no difference between intervention and control arms for the primary clinical outcome of glycemic control measured by HbA1c levels. Although there was low usage of the app among participants, results indicate contextual factors, particularly site, had a significant impact on overall usage. Future research into the patient and site-specific factors that increase app utilization are needed. Trial Registration: Clinicaltrials.gov NCT02813343; https://clinicaltrials.gov/ct2/show/NCT02813343 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT02813343)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With respect to glycemic control, telehealth appears noninferior (as good or superior) to traditional health care delivery for persons with T1D or T2D, particularly in those who require more interactions, are newly diagnosed, have higher A1C levels, are diagnosed with GDM, or have other comorbid conditions.1673–1681”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1676]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 2×
“Data were collected centrally by research assistants and inputted into the REDCap database.”
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 1×
“The worldwide burden of type 2 diabetes mellitus (T2DM) continues to increase, with almost 9% of the global population expected to have T2DM by 2035 [1].”
Self-citationEffect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Eysenbach, G. (2005) · Journal of Medical Internet Research · doi:10.2196/jmir.7.1.e11 · Cited by 2,524 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Self-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1159 · Cited by 1,750 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.011 · Cited by 1,389
A Systematic Review of the Impact of Adherence on the Effectiveness of e-Therapies
Donkin, L., Christensen, H., Naismith, S. L., Neal, B., Hickie, I. B., & Glozier, N. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1772 · Cited by 876 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Whitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743 · cited 1×
“There are a growing number of mobile apps designed to improve the self-management of T2DM patients [10-12], although few have been rigorously evaluated.”
Research works printed but not linked: 1
- Gude, W, 2016, Stud Health Technol Inform, 228, 594
Cited by
Items 101–200 of 208
Benevides, A. M. L. N., Rabelo, J. A. F., Soares, P. R. D. H., Marçal, E., Ferreira, L. F. D. A., & Medeiros, M. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i14.21823 · Cited by 4
Physician-Authored Feedback in a Type 2 Diabetes Self-management App: Acceptability Study
Potter, E., Burstein, F. V., Flynn, D., Hwang, I., Dinh, T., Goh, T. Y., Ebrahim, M. M., & Gilfillan, C. P. (2022) · JMIR Formative Research · doi:10.2196/31736 · Cited by 9
“Several studies [6,32-34] found a high degree of patient satisfaction with receiving SMS text messages (whether motivational or educational) and that patients found this useful and beneficial.”
BackgroundDaud, M. H., Yusoff, F. H., & Ramli, A. S. (2023) · Journal of Clinical and Health Sciences · doi:10.24191/jchs.v8i1.21452 · Cited by 5
Iyawa, G. E., Ondiek, C. O., & Osakwe, J. (2019) · Advances in healthcare information systems and administration book series · doi:10.4018/978-1-7998-0261-7.ch001 · Cited by 6
Varma, N., Cygankiewicz, I., & Turakhia, M. P. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4420 · Cited by 7
Bulaj, G. W., Coleman, M., Johansen, B., Kraft, S., Lam, W., Phillips, K., & Rohaj, A. (2024) · Pharmacy · doi:10.3390/pharmacy12040107 · Cited by 5
Liu, M., Wu, X., Li, Z., Tan, D., & Huang, C. (2024) · JMIR mhealth and uhealth · doi:10.2196/53805 · Cited by 5
“Summary studies of apps for mental health, chronic disease management, exercise, and medication adherence found that the lack of scientific validation of apps was a recurring issue [14,18,19,22,23].”
BackgroundBuendía, R., Havsol, J., Lundberg, V., Sooben, K., Jornten-Karlsson, M., Nyman, E., Khan, F. M., & Dennis, G. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630389 · Cited by 4
“those results were not confirmed in a large multi-center independent trial [8].”
BackgroundResultInfluentialKay, M. C., Miller, H., Askew, S., Spaulding, E. M., Chisholm, M., Christy, J., Yang, Q., & Steinberg, D. (2022) · AJPM Focus · doi:10.1016/j.focus.2022.100037 · Cited by 7
Inchusri, T., Surangsrirat, D., Kwanmuang, P., Poomivanichakij, P., Apiwatgaroon, P., Ongprakobkul, S., Kongchu, A., Klinpikul, A., Taneeheng, A., Pruphetkaew, N., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/45374 · Cited by 6
Berlot, A., Chen, P. S., Kaur, S., Mowrey, W. B., Mahali, L. P., Gonzalez, J. S., Wylie‐Rosett, J., Golestaneh, L., & Jariwala, S. P. (2023) · Clinical Diabetes · doi:10.2337/cd23-0034 · Cited by 5
TERKEŞ, N., Bektaş, H., & Aydemir, M. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.09.002 · Cited by 7
Öçal, P. (2023) · The European Research Journal · doi:10.18621/eurj.1320822 · Cited by 6
Jacobs, M., van der Weegen, W., Savelberg, H. H. C. M., de Bie, R. A., van Beek, R., Kuipers, J., & Pilot, P. (2025) · Patient Education and Counseling · doi:10.1016/j.pec.2025.109333 · Cited by 5
Lee, C. S., Antoniadou, M., Jaarsma, T., Riegel, B. J., & Westland, H. (2025) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2025.100476 · Cited by 6
“…Jaipakdee et al., 2015; Lee et al., 2017; Bosi et al., 2013; Lorig et al., 2010; Hermanns et al., 2012; Abraham et al., 2020; Aceti et al., 2021; Agarwal et al., 2019; Ahrary et al., 2020; Al Omar et al., 2020; Ali et al., 2020; Bluml et al., 2019; Bukhsh et al., 2022; Cox et al., 2020; Crasto…”
Longhini, J., Pedrotti, D., Foladori, F., Stedile, M., Stefani, F., Ben, M. D., Froner, A., Pesci, M. P., Toccoli, S., & Brugnolli, A. (2026) · Journal of Medical Internet Research · doi:10.2196/88708 · Cited by 8
“Glucose monitoring: the pooled estimate from 4 RCTs mixing different types of digital interventions [31,45,59,77] showed that digital interventions may result in little to no difference in glucose monitoring self-care compared with usual care (SMD=0.76, 95% CI –0.40 to 1.93; I 2 =93%; Figure 2),…”
InfluentialKapur, R., Sharma, R., Kanwar, V., Bhavsar, A. V., & Dutt, V. (2024) · International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) · doi:10.1145/3652037.3663926 · Cited by 3
“For instance, the BlueStar app offered by [1] only tracks the BGL of a person and, hence, experiences a low usage among its participants.”
MethodAkano, K., & Sugihara, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-090066 · Cited by 4
“As 15–17 While various digital health interventions have been proposed to improve the mental health of PWD, 18–21 studies with high levels of evidence are scarce, underscoring the need for robust clinical trials.”
The Voice of Endo: Leveraging Speech for an Intelligent System That Can Forecast Illness Flare-ups
Pichon, A., Blumberg, J. R., Mamykina, L., & Elhadad, N. (2025) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3706598.3714040 · Cited by 4
“Personal informatics apps designed for various diseases — Trackly for multiple sclerosis [7], BlueStar for type 2 diabetes [3], and Jointfully for osteoarthritis [45] — have encouraged participation in health-promoting behaviors.”
Mohan, V., Kalra, S., Augustine, A., & Kober, J. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01768-x · Cited by 6
Rindarwati, A., Amalia, L., & Permana, H. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e160083 · Cited by 5
“For example, a multicenter pragmatic RCT of the BlueStar mobile app in the United States showed no significant difference in HbA1c reduction between intervention and control groups after 3 months (Agarwal et al. 2019), largely due to low and variable app engagement.”
Lara, T. R., Muñoz-Torres, A. V., Salmerón, G. M., Vela, D., Bravo, P. M., Roy-García, I. A., & López, L. V. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.07.011 · Cited by 4
Smit-Ckd: A Mobile App To Improve Adherence To Therapy In Ckd Patients. A Pilot Study
Vilasi, A. D., Panuccio, V. A., Morante, S., Villa, A., Versace, M. C., Mercuri, S., Vigni, M. L., Tripepi, G. L., & Torino, C. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313505 · Cited by 3
“Bluestar, for example, an app validated in a clinical trial, helps reducing blood sugar providing a database for food intake monitoring and including personalized advice according to the goals indicated by the customers [17].”
BackgroundWang, R., Rouleau, G., Booth, G. L., Brazeau, A., El‐Dassouki, N., Taylor, M., Cafazzo, J. A., Greenberg, M., Nakhla, M. M., Shulman, R. M., et al. (2023) · JMIR Research Protocols · doi:10.2196/46115 · Cited by 6
“This was a conscious decision, as many RCTs show suboptimal results [71,92,93], suggesting a need to focus on upstream outcomes such as engagement as a first step.”
Self-citationZakwan, M., Thamrin, N., Shauri, R. L. A., Jailani, R., Manaf, H., & Mustapa, N. A. (2024) · International Journal of Advanced Technology and Engineering Exploration · doi:10.19101/ijatee.2023.10102368 · Cited by 5
Chew, B., Lai, P. S. M., Sivaratnam, D., Basri, N. I., Appannah, G., Yusof, B. N. M., Thambiah, S. C., Hanipah, Z. N., Wong, P. F., & Chang, L.-C. (2025) · Health Systems & Reform · doi:10.1080/23288604.2024.2417788 · Cited by 5
“122,124 The content development, validation and deployment are to be sound for all kind of clinical interventions even more so for digital interventions infused with mathematical algorithms of AI.”
Yuksel, M., & Bektaş, H. (2021) · Turkiye Klinikleri Journal of Nursing Sciences · doi:10.5336/nurses.2020-77016 · Cited by 12
Mobile medical applications’ state quo and underlying barriers: review of literature †
Zhou, T., Mao, J., Xie, L., Zhao, Q., & Chen, Y.-L. (2022) · Frontiers of Nursing · doi:10.2478/fon-2022-0029 · Cited by 2
Lu, D., Jiang, W., Ai, D., Cen, C., Ou, Q., Chen, K., & Zhang, J. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14376 · Cited by 2
“Therefore, the app is recommended for patients with diabetes who were titrating basal insulin to proper doses 10 .”
InfluentialMobile Apps to Improve Diabetes Mellitus Self-care: A Scoping Review
Pérez-Osorio, K.-C., Nieto, Y. A. J., González-Diaz, J.-E., Rodríguez-Vásquez, G., Parada, A. R., & Juárez-Rivera, O. (2025) · Studies in computational intelligence · doi:10.1007/978-3-031-90310-6_26 · Cited by 2
Wang, R., Panesar, B., SONNENBERG, M., Landry, A., Brazeau, A., Greenberg, M., Nakhla, M. M., Zenlea, I. S., Mok, E., Kichler, J., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/70401 · Cited by 3
“Second, recognizing that many RCTs yield suboptimal results in distal outcomes [79,80], we timed our data collection alongside the trial.”
Self-citationWongdama, S., Paemueang, W., & Sriphrapradang, C. (2025) · JMIR Diabetes · doi:10.2196/83685 · Cited by 5
“For example, the BlueStar diabetes app—the first Food and Drug Administration–approved mobile prescription therapy in the United States—showed no significant HbA 1c level reduction in a multicenter pragmatic trial in Canada, likely due to the main barrier of low app use [16].”
Butt, M. D., Ong, S. C., Javaid, I., & Malik, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-38999-2 · Cited by 2
“Attenuation by 6 months likely reflects waning engagement, habit formation challenges, and variability in intervention components and adherence 12,30,31 .”
IoT framework of telerehabilitation system with wearable sensors for diabetes mellitus patients
Karim, M. Z. A., Jailani, R., Shauri, R. L. A., & Thamrin, N. M. (2023) · Indonesian Journal of Electrical Engineering and Computer Science · doi:10.11591/ijeecs.v31.i2.pp1023-1031 · Cited by 3
Sae-lee, K., Surangsrirat, D., Parlawong, C., Anawilkul, T.-T., Assawachamrun, N., Boonbandan, P., Ladapongpuwat, P., Chupetch, B., Thongchai, S., Pruphetkaew, N., et al. (2023) · JMIR Formative Research · doi:10.2196/45298 · Cited by 4
“mHealth apps are effective and low-cost tools used to promote health among patients with certain conditions and chronic diseases, including hypertension, obesity, diabetes, and dyslipidemia [2,6-9].”
BackgroundAziz, S. H. A., Sultan, E. A. E. M., Ramadan, H., & Elmetwaly, O. I. A. (2023) · Egyptian Nursing Journal · doi:10.4103/enj.enj_6_23 · Cited by 2
AI-powered medical devices for practical clinicians including the diagnosis of colorectal polyps
Kim, D., & Kim, E. S. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.11.658 · Cited by 3
Ghaben, S. J., & Ludin, A. F. M. (2024) · Biomedical engineering · doi:10.5772/intechopen.1004756 · Cited by 3
Tanhapour, M., Mohammadzadeh, N., Kalhori, S. R. N., Shakibian, H., Peimani, M., & Nasli‐Esfahani, E. (2024) · Universal Access in the Information Society · doi:10.1007/s10209-024-01138-7 · Cited by 2
Hayashi, K., Imai, H., Oikawa, I., Ishihara, Y., Wakuda, H., Miura, I., Uenohara, S., Kuwae, A., Kai, M., Furuya, K., et al. (2024) · JMIR Formative Research · doi:10.2196/56376 · Cited by 4
“For instance, apps designed to educate patients on lifestyle modifications have proven effective in reducing blood pressure [5] and hemoglobin A 1c [6] in clinical trials and are approved for clinical use, although challenges with long-term app adherence persist in the real world [7,8].”
BackgroundOrbayinah, S., Hikmah, N., Arviani, S. D., Hidayah, F. N., Soularto, D. S., Cahyaningsih, I., Romdzati, Hadning, I., Ghozali, M. T., Pamungkas, K. A., et al. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202413502002 · Cited by 4
Tele-Healthcare Monitoring System-Based for the Management of Diabetes Emergencie
Ogunniyi, J. O., Emuoyibofarhe, J. O., & Olamoyegun, M. A. (2021) · E-Health Telecommunication Systems and Networks · doi:10.4236/etsn.2021.104005 · Cited by 3
Digital health apps for people with diabetes
Hester, J. C., Zabala, Z. E., Winskell, K., & Pasquel, F. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90557-2.00015-7 · Cited by 4
Outcomes assessment for digital health interventions in diabetes: a payer perspective
Silberman, J., Sarlati, S., Kaur, M., & Bokhari, W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90557-2.00023-6 · Cited by 2
Apps as a health education tool for people with diabetes mellitus: what is available in Portuguese?
Lemos, B. O., Gebrim, T. D. F. D. O., de Abreu, M. C. F., Dullius, J., & Ginani, V. C. (2023) · Saúde e Sociedade · doi:10.1590/s0104-12902023220930en · Cited by 2
Zhong, S., Jiang, J., Liu, H., & Pan, Y. (2024) · Trials · doi:10.1186/s13063-024-07950-z · Cited by 4
“However, the use of the application varied among the trial sites [18].”
BackgroundThe Effectiveness of Telenursing for Diabetes Self-management Education: A Scoping Review
Marlina, T. T., Haryani, H., Widyawati, W., & Febriani, D. H. (2023) · The Open Nursing Journal · doi:10.2174/18744346-v17-230815-2023-38 · Cited by 9
“Agarwal et al., 2019 Application of diabetes T1: 3 months T2: 6 months Immediate treatment group (ITG): The participants received virtual coaching with the blue star application for six months.”
Lemos, B. O., Gebrim, T. D. F. D. O., de Abreu, M. C. F., Dullius, J., & Ginani, V. C. (2023) · Saúde e Sociedade · doi:10.1590/s0104-12902023220930pt · Cited by 8
Gallagher, R. D., Neubeck, L., Davis, A. J., Redfern, J., Parker, H. M., Hyun, K. K., Chow, C. K., Celermajer, D. S., Buckley, T. A., Schumacher, T. L., et al. (2024) · Games for Health Journal · doi:10.1089/g4h.2024.0174 · Cited by 2
“8,19,20 Usage data logs and self-reports con fi rmed this pattern in MyHeartMate users.”
Kalra, S., Kalra, P., Gangopadhyay, K. K., Julka, S., Lakhani, O., Chawla, M. S., Ramakrishnan, S., & Wasir, J. S. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01747-2 · Cited by 1
“A randomized trial of diabetes specific app showed that each additional day of app use corresponded with a 0.016-point decrease in participants’ 3-month HbA1c levels [35].”
InfluentialPark, G., Lee, H., Lee, M. J., & Khang, A. R. (2025) · Western Journal of Nursing Research · doi:10.1177/01939459251374937 · Cited by 1
“42 In that study, no statistically significant association was found between overall app use and self-care activities.”
Yioukka, M., Dinas, P. C., Ntoumas, I., Karatzaferi, C., & Sakkas, G. K. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102229 · Cited by 2
Rameh, F., Farahani, A. S., Nourian, M., Tabatabayi, S. A., & Nasiri, M. (2026) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2025.12.028 · Cited by 1
Dsouza, S. M., Shetty, S., Suvarna, R., Pundir, P., Rajkhowa, P., Lewis, M. G., & Brand, H. (2026) · BMC Public Health · doi:10.1186/s12889-026-27908-x · Cited by 1
“In recent years, there has been an increasing number of DHIs meant to help T2D patients manage their condition, but only a few have been thoroughly evaluated among the general population globally [11].”
Vyas, V., Singh, K., Pareek, P., Garg, M. K., Didel, S., Priyanka, P., Goel, A. D., & Misra, S. (2022) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmac013 · Cited by 1
Cai, H., Chen, H., Gao, Y., Huang, Q., Lv, C., Cang, X., Qi, J., Luo, K., & Jin, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-26649-2 · Cited by 1
Jiang, Y., & Wang, Y. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230605124450 · Cited by 1
Diabetes Self-Management Education (DSME) Methods using Web-Based and Application
Harimahardika, G. S., & Agustini, N. L. P. I. B. (2023) · Babali Nursing Research · doi:10.37363/bnr.2023.44246 · Cited by 3
“Studies consistent with the average systematic review were carried out in Indonesia with 5 studies [15]; [16]; [17], and the others were two studies in America [18]; [19] and one study each in Canada, Iran, and Australia [20]; [21]; [22].”
BackgroundResultData analysis in diabetes and the role of technology in diabetes management
Rangaswamy, U. K., Ratan, C., kumar, S. S., Anil, A. A., Rajesh, D., & Krishnan, A. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29129-6.00013-0 · Cited by 2
Русанов, А. Н., & Родионова, Т. И. (2021) · Современные проблемы науки и образования · doi:10.17513/spno.31002 · Cited by 1
Zhang, J., Liu, X., Wei, L., Zeng, Q., & Lin, K. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01115-x · Cited by 1
“The use of computers for self-management has not only been proved to be effective in controlling blood glucose, but its portability has gradually emerged with the popularity of tablet computers and laptops [47].”
BackgroundCarrera, F. J. R., Ques, Á. A. M., & Clavería, A. (2020) · Research Square · doi:10.21203/rs.3.rs-115192/v1 · Cited by 1
“Indeed the results of a recent pragmatic multicenter clinical random controlled trial did not indicate any differences between the IG (intervention group) and the CG for the primary clinical outcome of glycemic control measured by HbA1c, which also occurred in secondary outcomes like quality of life and behaviors stem…”
Darabi, Z., Araban, M., Azizi, A. A., Angali, K. A., & Borazjani, F. (2020) · doi:10.21203/rs.3.rs-62956/v1 · Cited by 1
Sinha, A. P., Joshi, A., Singhal, M., & Gupta, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1680004/v2 · Cited by 1
Pragmatic trials: ignoring a mediator and adjusting for confounding
Pericleous, P. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4188-1
Mobile Applications for Behavioral Change: A Systematic Literature Review
Ofori, M. Q., & El-Gayar, O. (2020) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-6067-8.ch011 · Cited by 2
Poonprapai, P., Lerkiatbundit, S., & Saengcharoen, W. (2021) · Research Square · doi:10.21203/rs.3.rs-772978/v1
Sinha, A. P., Singhal, M., Gupta, M., & Joshi, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1680004/v1 · Cited by 1
Salas-Groves, E., Galyean, S., Alcorn, M., & Childress, A. (2022) · doi:10.2196/preprints.41235
Vilasi, A. D., Panuccio, V. A., Morante, S., Villa, A., Versace, M. C., Mezzatesta, S., Mercuri, S., Inguanta, R., Aiello, G., Cutrupi, D., et al. (2022) · doi:10.2196/preprints.36766
Takeda, Y., NAKAYAMA, T., & Furukawa, K. (2022) · Rigakuryoho Kagaku · doi:10.1589/rika.37.611
Xie, Q., Hu, X., Wang, Y., Peng, J., & Cheng, L. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063814
The effects of online equipment on management of patients with type 2 diabetesPreprint
Xu, M., Li, J., Peng, Y. H., Zheng, Q., Wang, Y., Ke, T., Zhao, D., Dai, Y., Dong, Q., Ji, B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2646227/v1
SIRIPATH, N. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.463 · Cited by 1
Desveaux, L., Budhwani, S., Stamenova, V., Bhattacharyya, O. K., Shaw, J., & Bhatia, R. S. (2023) · doi:10.32920/24191463
Self-citationDesveaux, L., Budhwani, S., Stamenova, V., Bhattacharyya, O. K., Shaw, J., & Bhatia, R. S. (2023) · doi:10.32920/24191463.v1
Self-citation"SEDIA" PROGRAMME BASED ON STRUCTURED SUPPORTIVE EDUCATION TO INCREASE SELF-EFFICACY OF DIABETICS
Pratiwi, I. N., Widyawati, I. Y., Nimah, L., Dewi, L. C., & Tauhidiyah, S. (2023) · Jurnal Pengabdian Masyarakat Dalam Kesehatan · doi:10.20473/jpmk.v5i2.48725
Madhuri, N. U., & Yaashikaa, P. R. (2023) · AIP conference proceedings · doi:10.1063/5.0173436
Prevention and control of diabetes mellitus complications in productive population in rural
Nurlatif, R. V., Sumardiyono, S., & Rahardjo, S. S. (2023) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v13i1.23424
Asakura, E., Brain, D., Senanayake, S. J., & Barnett, A. G. (2024) · doi:10.2196/preprints.62883
Self-Management Mentoring Model in Improving the Health Quality of Life of Productive Age Diabetics
Nurlatif, R. V., Sumardiyono, S., & Rahardjo, S. S. (2024) · KnE Social Sciences · doi:10.18502/kss.v9i24.16884
Alkharis, V. Z., Asiandi, A., Supriyadi, S., & Purwandari, R. D. (2024) · Revista de Gestão Social e Ambiental · doi:10.24857/rgsa.v18n10-269
Noda, Y., Kometani, M., Nomura, A., Noda, M., Oka, R., Kadono, M., & Yoneda, T. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000648
Enhancing Emotional Intelligence in Healthcare: The Impact of Sentient Applications
Paul, T. J., Dutta, D., Singh, A., Misbah, M., Aran, K. R., & Raj, R. G. (2024) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-7011-7.ch010 · Cited by 1
“Evaluating the Effectiveness of Mobile Health (mHealth) Interventions in Managing Type 2 Diabetes”
Choudhur, C. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3.5654
Aswan, L. O., Yusuf, S., Farawansah, F., & Ma'ge, A. (2025) · doi:10.2196/preprints.75041
Yang, Z., Tan, Z., Sun, M., Zhang, J., Hou, H., & Li, X. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01802-2 · Cited by 1
Development of Android-based “Manis” application for diabetes mellitus management
Harimahardika, G. S., Agustini, N. L. P. I. B., Megayanti, S. D., Sari, N. M. C. C., & Suyasa, I. G. P. D. (2025) · Healthcare in Low-resource Settings · doi:10.4081/hls.2025.13514
Aboagye, A., Peckham, J., Hearld, K. R., Abdullah, S., & Thirumalai, M. (2025) · JMIR Research Protocols · doi:10.2196/71495 · Cited by 1
Mobile Technology Adoption in Healthcare—A Behavioral Understanding of Chronic Patients’ Perspective
Șerban, A. M., & Druică, E. (2025) · Clinics and Practice · doi:10.3390/clinpract15100181 · Cited by 1
“Older patients, those with lower individual motivation, and those with lower perceived usefulness of digital health tools were less likely to engage with the app [33].”
Takei, S., Hamada, K., Shimizu, N., Sakurai, M., Nojiri, T., & Yahagi, N. (2025) · medRxiv · doi:10.64898/2025.12.14.25342210
Zhong, S., Jiang, J., Liu, H., & Pan, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25132096
Carrera, A., Manetti, S., & Lettieri, E. (2024) · Figshare · doi:10.6084/m9.figshare.25282834
Dsouza, S. M., Venne, J., Shetty, S., & Brand, H. (2024) · Figshare · doi:10.6084/m9.figshare.26755675
Gomez, M. H. S., Luna, N. A. B., Bawal, D. Y. V., Caro, M. K. C., & Gomez, M. F. C. S. (2024) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.11b4945936
Fan, F., Huang, H., Yan, J., Xu, C.-Y., Wu, X., Zhou, C., Wen, D., Huang, H., Li, H. C., & Qiu, Y. (2026) · JMIR Cancer · doi:10.2196/83375 · Cited by 3
“DTx are interventions delivered via digital platforms [13], which have the potential to mitigate the challenges posed by chronic diseases, such as enhancing patient adherence and improving patient self-management [14].”
Peng, H., Huang, W., Zhang, S., Peng, Q., Zhou, L., Feng, J., Liu, M., & Peng, D. (2026) · Research Square · doi:10.21203/rs.3.rs-8986027/v1
Fereidooni, G. J., Zarei, F., & Ghofranipour, F. F. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03326-1 · Cited by 2
“For instance, Agrawal et al. reported no significant change in HbA1c levels following an educational intervention [60].”
Wang, J., Li, C., Yang, Y., Bhandari, B., & Coleman, D. C. (2026) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106261438832
Metadata
- Authors
- Agarwal, P., Mukerji, G., Desveaux, L., Ivers, N. M., Bhattacharyya, O., Hensel, J. M., Shaw, J., Bouck, Z., Jamieson, T., Onabajo, N., Cooper, M., Marani, H., Jeffs, L., & Bhatia, R. S.
- Affiliations
- University of Toronto (CA)
- Women's College Hospital (CA)
- St. Michael's Hospital (CA)
- Corresponding author
- Agarwal, Payal
- ORCID
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-01-10
- Volume
- 7
- Issue
- 1
- Pages
- e10321
- ISSN
- 2291-5222 (ISSN-L)
- PMC
- PMC6329896
- OpenAlex
- W2891497594
- Cited by
- 208
- References
- 41
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 39 · 2023: 32 · 2022: 32 · 2021: 35 · 2020: 18 · 2019: 5
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR mhealth and uhealth (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, mobile health apps, diabetes self-management, glycemic control, HbA1c, app usage, diabetes self-efficacy, quality of life, health care utilization, real-world evidence, patient experience, Problem Areas in Diabetes, Summary of Diabetes Self-Care Activities, EuroQol
- MeSH terms
- Self-Management, Adult, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Ontario, Surveys and Questionnaires, Blood Glucose Self-Monitoring, Mobile Applications, Pragmatic Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.